Health IT Analytics July 13, 2020
Three collaborative COVID-19 research efforts will use precision medicine principles to optimize therapy effectiveness.
The San Antonio Partnership for Precision Therapeutics (SAPPT) has announced the funding of three projects that will accelerate treatments for COVID-19 using precision medicine principles.
Launched in 2019 to accelerate the process of getting therapies and pharmaceuticals from basic research to people in need, SAPPT was created by four leading San Antonio research organizations: Southwest Research Institute, Texas Biomedical Research Institute, The University of Texas Health Science Center at San Antonio, and The University of Texas at San Antonio.
SAPPT has awarded more than $600,000 to fund these projects, made possible through the USAA’s commitment of $1 million to organizations combating COVID-19. SAPPT organized and issued...
Today's Sponsors
Today's Sponsor